Risk of COVID-19 in Patients With Cancer-Reply
JAMA Oncol
.
2020 Sep 1;6(9):1472-1473.
doi: 10.1001/jamaoncol.2020.2589.
Authors
Melvin L K Chua
1
2
3
,
Jing Yu
3
4
5
,
Conghua Xie
3
4
5
Affiliations
1
Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
2
Oncology Academic Programme, Duke-NUS Medical School, Singapore.
3
Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
4
Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
5
Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
PMID:
32614375
DOI:
10.1001/jamaoncol.2020.2589
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Betacoronavirus*
COVID-19
Coronavirus Infections*
Humans
Neoplasms* / epidemiology
Pandemics*
Pneumonia, Viral*
SARS-CoV-2